The Pfizer-BioNTech COVID-19 vaccine is less effective against the Omicron virus variant than other strains of the CCP virus, the companies said Wednesday, citing a study they ran. Scientists found on average a more than 25-fold reduction in neutralizing antibodies against the Omicron variant compared to the wild type, “indicating that two doses of BNT162b2 may…
Pfizer-BioNTech COVID-19 Vaccine Less Effective Against Omicron: Companies
Australia’s Drug Regulator Grants Pfizer Vaccine Provisional Approval for 5-11 Year Olds
A coronavirus vaccine for children as young as five has taken a step closer in Australia to being recommended and could be available early in the new year. The Therapeutic Goods Administration has given its provisional approval for Pfizer’s COVID-19 vaccine for five to 11 year olds. “In making this regulatory decision, the TGA carefully…
Canada Buying up to 1.5 Million Courses of Oral Antiviral Drugs to Fight COVID 19
OTTAWA—Canada is buying up to 1.5 million courses of oral antiviral treatments for COVID-19 in anticipation of them being approved by Health Canada. The government has signed up for an initial one million courses of antiviral treatment from Pfizer, once Health Canada endorses their safety and efficacy.The company submitted a request for approval to the…
What Do We Know About Omicron?
December 2, 2021
admin
AfricaArchivedBotswanaCCPCCP VirusCoronavirus In-Depthdelta variantDr. Scott GottliebInternationalModernaNaming the VirusNewsOmicron variantPfizerRegeneronSouth AfricaVaccines & SafetyWorld
0 Comment
It’s been just days since a new strain of COVID-19 made headlines across the planet. While the World Health Organization (WHO) has warned that the new Omicron variant presents a “very high risk,” other scientists, including some with WHO, have stressed that we still have much to learn about the new CCP (Chinese Communist Party)…
Pfizer Prepares Shipments of Oral Antiviral COVID-19 Treatment Pill for Distribution Across Europe and US
Pharmaceutical giant Pfizer has prepared the first shipments of its COVID-19 oral antiviral pill, which “significantly” reduces the risk of hospitalization and death for high-risk patients, and sent them to the airport for distribution across Europe and America pending approval, it announced Tuesday. “Thrilled to see the first shipments of our COVID-19 antiviral candidate head to…
They’re Coming for the Kids
Commentary On Nov. 19, Health Canada authorized the Pfizer COVID-19 vaccine for 5- to 11-year-olds. Its decision followed in the footsteps of the U.S. Food and Drug Administration’s emergency use authorization on Oct. 29 for the same age group. Canadian public health authorities are now ramping up clinics in and near schools. Toronto Mayor John…
Pfizer Says It Could Rework COVID-19 Vaccine to Counter New Variant in 100 Days
Pfizer and BioNTech announced on Friday that its COVID-19 vaccine could be reworked in “approximately 100 days” to counter a new variant of the CCP virus that may be able to penetrate through vaccines. The U.S.-based pharmaceutical company said in a statement obtained by news agency Reuters it expects more data on B.1.1.529, the new variant…
Vietnam Says Pfizer, MSD to Grant Its Firms Licenses to Produce COVID-19 Pills
HANOI—Drugmakers Pfizer Inc and MSD, known as Merck & Co Inc in North America, have agreed to give licenses to firms in Vietnam to produce COVID-19 treatment pills, Vietnam’s ministry of health said on Friday. The companies have sent letters of approval to the Drug Administration of Vietnam, the ministry said in a statement, for…
New Analysis Shows Merck’s COVID-19 Antiviral Treatment Has Lower Efficacy
A new analysis of clinical trial results shows that Merck’s antiviral pill for treating COVID-19 is significantly less effective than previously reported in October, the company announced on Friday. In the updated report, the drugmaker said its antiviral treatment drug, which is called molnupiravir, showed a 30 percent reduction in hospitalizations and deaths from the…
All Australians to Be Urged to Get COVID-19 Boosters
Letters will be sent to 11.3 million Australian homes before Christmas urging people to get COVID-19 booster shots, Prime Minister Scott Morrison confirmed. Morrison said the booster program would be essential for the nation to avoid another round of virus infection. “Thanks to the high vaccination rates, we are now reopening. Our economy is strongly…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`